Research News

The FDA has approved the first interchangeable biosimilar for adalimumab (Humira), a TNF inhibitor commonly taken for spondyloarthritis…

Among adults with rheumatic diseases including spondyloarthritis, who received COVID-19…

The incidence of ankylosing spondylitis (AS) did not differ significantly…

Fibromyalgia, a chronic pain condition commonly thought to originate in the brain,…

The FDA said the trial results showed elevated risks of…

Those with moderately to severely compromised immune systems who received…